Drugs standards group nixes plan to kick pharma's crab blood habit

Horseshoe crabs' icy-blue blood will remain the drug industry's standard for safety tests after a powerful U.S. group ditched a plan to give equal status to a synthetic substitute pushed by Swiss biotech Lonza and animal welfare groups.

from Reuters: Money News https://ift.tt/2ZQK4Xl
via IFTTT

• Tweet
• Share
• Share
• Share
• Share